Evidence map›Paper›PMID 36826687›Full record

ArticlePharmacoEconomics2023

Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK.

Junwen Zhou, Runguo Wu, Claire Williams, Jonathan Emberson, Christina Reith, Anthony Keech, John Robson, Kenneth Wilkinson, Jane Armitage, Alastair Gray and 3 more

Open access · hybridAbstract read
In one paragraph

Article in PharmacoEconomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Junwen ZhouHealth Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, OX3 7LF, Oxford, UK.
Runguo WuHealth Economics and Policy Research Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Claire WilliamsHealth Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, OX3 7LF, Oxford, UK.
Jonathan EmbersonMRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Christina ReithClinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Anthony KeechNHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
John RobsonClinical Effectiveness Group, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Kenneth Wilkinson, Oxfordshire, UK.
Jane ArmitageMRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Alastair GrayHealth Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, OX3 7LF, Oxford, UK.
John SimesNHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
Colin BaigentMRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Borislava MihaylovaHealth Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, OX3 7LF, Oxford, UK. boby.mihaylova@dph.ox.ac.uk.ORCID http://orcid.org/0000-0002-0951-1304
University of Oxford · GBQueen Mary University of London · GBThe University of Sydney · AUBerkshire Buckinghamshire and Oxfordshire Wildlife Trust · GB

Funding

British Heart Foundation CH/1996001/9454Department of Health 17/140/02
6 · The paper itself

Abstract

objectivesThe aim of this study was to develop prediction models for the individual-level impacts of cardiovascular events on UK healthcare costs.

methodsIn the UK Biobank, people 40-70 years old, recruited in 2006-2010, were followed in linked primary (N = 192,983 individuals) and hospital care (N = 501,807 individuals) datasets. Regression models of annual primary and annual hospital care costs (2020 UK£) associated with individual characteristics and experiences of myocardial infarction (MI), stroke, coronary revascularization, incident diabetes mellitus and cancer, and vascular and nonvascular death are reported.

resultsFor both people without and with previous cardiovascular disease (CVD), primary care costs were modelled using one-part generalised linear models (GLMs) with identity link and Poisson distribution, and hospital costs with two-part models (part 1: logistic regression models the probability of incurring costs; part 2: GLM with identity link and Poisson distribution models the costs conditional on incurring any). In people without previous CVD, mean annual primary and hospital care costs were £360 and £514, respectively. The excess primary care costs were £190 and £360 following MI and stroke, respectively, whereas excess hospital costs decreased from £4340 and £5590, respectively, in the year of these events, to £190 and £410 two years later. People with previous CVD had more than twice higher annual costs, and incurred higher excess costs for cardiovascular events. Other characteristics associated with higher costs included older age, female sex, south Asian ethnicity, higher socioeconomic deprivation, smoking, lower level of physical activities, unhealthy body mass index, and comorbidities.

conclusionsThese individual-level healthcare cost prediction models could inform assessments of the value of health technologies and policies to reduce cardiovascular and other disease risks and healthcare costs. An accompanying Excel calculator is available to facilitate the use of the models.

Indexed as

Cardiovascular DiseasesDiabetes MellitusMyocardial InfarctionStrokeAdultAgedFemaleHealth Care CostsHumansMiddle AgedUnited Kingdom

Identifiers

PMID36826687
PMCPMC10085892
OpenAlexW4321749319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.